A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer Patients
Clinical trial NCT03343145 · COMPLETED
Trial details
- NCT number
- NCT03343145
- Sponsor
- Dong-A ST Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-12
- Primary completion
- 2019-01-28
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.